Prognostic Value of Human Equilibrative NucleosideTransporter1 in Pancreatic Cancer Receiving Gemcitabin-Based Chemotherapy: A Meta-Analysis

• Zhu-Qing Liu ,

  Contributed equally to this work with: Zhu-Qing Liu, Ying-Chao Han, Xi Zhang

  Affiliation Department of Medical Oncology, Shanghai Tenth People’s Hospital, Tongji University, School of Medicine, Shanghai, China

  ⨯
• Ying-Chao Han ,

  Contributed equally to this work with: Zhu-Qing Liu, Ying-Chao Han, Xi Zhang

  Affiliation Department of Spine Surgery, Shanghai East Hospital, Tongji University, School of Medicine, Shanghai, China

  ⨯
• Xi Zhang ,

  Contributed equally to this work with: Zhu-Qing Liu, Ying-Chao Han, Xi Zhang

  Affiliation Department of Medical Oncology, Shanghai Tenth People’s Hospital, Tongji University, School of Medicine, Shanghai, China

  ⨯
• Li Chu,

  Affiliation Department of Medical Oncology, Shanghai Tenth People’s Hospital, Tongji University, School of Medicine, Shanghai, China

  ⨯
• Jue-Min Fang,

  Affiliation Department of Medical Oncology, Shanghai Tenth People’s Hospital, Tongji University, School of Medicine, Shanghai, China

  ⨯
• Hua-Xin Zhao,

  Affiliation Department of Medical Oncology, Shanghai Tenth People’s Hospital, Tongji University, School of Medicine, Shanghai, China

  ⨯
• Yi-Jing Chen,

  Affiliation Department of Medical Oncology, Shanghai Tenth People’s Hospital, Tongji University, School of Medicine, Shanghai, China

  ⨯
• Qing Xu

  * E-mail: qingxumed@163.com

  Affiliation Department of Medical Oncology, Shanghai Tenth People’s Hospital, Tongji University, School of Medicine, Shanghai, China

  ⨯